Data / Form D filings / EPALEX Corp
EPALEX Corp: Form D filings
EPALEX Corp, a pharmaceuticals company in Mountain View, CA, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on November 10, 2025, reports $1.2 million sold of a $3.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1049 EL MONTE AVENUE, SUITE C 585, Mountain View, CA, 94040
- Phone
- 659-946-3366 X700
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1755010
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | New notice | $3,199,991 | $1,200,000 | $1,999,991 | 1 | Oct 31, 2025 | sec.gov |
| Dec 20, 2024 | New notice | $14,999,998 | $3,999,999 | $10,999,999 | 1 | Dec 9, 2024 | sec.gov |
| Oct 14, 2022 | New notice | $8,499,980 | $4,260,617 | $4,239,363 | 15 | Oct 4, 2022 | sec.gov |
| Dec 18, 2020 | Amendment | $20,296,275 | $20,296,275 | 7 | Dec 31, 2018 | sec.gov | |
| Jan 10, 2019 | New notice | $20,000,000 | $9,998,370 | $10,001,630 | 1 | Dec 31, 2018 | sec.gov |
| Nov 20, 2018 | New notice | $1,000,000 | $999,284 | $716 | 5 | Sep 1, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jon Saxe | Director | |
| Brendan Magrab | Executive Officer, Director | |
| Randall Murphy | Director | |
| Didric Cedarholm | Director | |
| Michael Rogawski | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 10, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EPALEX Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.